Acurx Pharmaceuticals, Inc. (ACXP) is a publicly traded company in the Unknown sector. Across all available filings, 3 corporate insiders have executed 13 transactions totaling $374.6K, demonstrating a bullish sentiment with $374.6K in net insider flow. The most recent transaction on Jan 19, 2024 involved a transaction of 19,737 shares valued at $70.1K.
No significant insider buying has been recorded for ACXP in the recent period.
No significant insider selling has been recorded for ACXP in the recent period.
Based on recent SEC filings, insider sentiment for ACXP is bullish with an Insider Alignment Score of 100/100 and a net flow of $374.6K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Acurx Pharmaceuticals, Inc. (ACXP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 3 insiders are actively trading ACXP stock, having executed 13 transactions in the past 90 days. The most active insider is Carl Sailer (Executive), who has made 4 transactions totaling $245.0K.
Get notified when executives and directors at ACXP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 19, 2024 | Sailer Carl | Executive | Option Exercise | 19,737 | $3.55 | $70.1K | |
| Jan 3, 2024 | P. Luci David | Executive | Option Exercise | 19,737 | $3.55 | $70.1K | |
| Jan 3, 2024 | J. Deluccia Robert | Executive | Option Exercise | 19,737 | $3.55 | $70.1K | |
| Dec 22, 2023 | J. Deluccia Robert | Executive | Gift | 30,000 | $N/A | $0 | |
| Dec 12, 2023 | J. Deluccia Robert | Executive | Gift | 40,000 | $N/A | $0 | |
| Jul 27, 2022 | P. Luci David | Executive | Purchase | 19,737 | $3.80 | $75.0K | |
| Jul 27, 2022 | J. Deluccia Robert | Executive | Purchase | 19,737 | $3.80 | $75.0K | |
| Jul 27, 2022 | Sailer Carl | Executive | Purchase | 19,737 | $3.80 | $75.0K | |
| Dec 2, 2021 | J. Deluccia Robert | Executive | Gift | 40,000 | $N/A | $0 | |
| Nov 23, 2021 | Sailer Carl | Executive | Purchase | 5,161 | $4.84 | $25.0K | |
| Nov 19, 2021 | P. Luci David | Executive | Purchase | 5,200 | $4.80 | $25.0K | |
| Nov 19, 2021 | J. Deluccia Robert | Executive | Purchase | 5,034 | $4.90 | $24.7K | |
| Jun 29, 2021 | Sailer Carl | Executive | Purchase | 12,500 | $6.00 | $75.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 7 | $374.6K | 64.1% |
Exercise(M) | 3 | $210.2K | 35.9% |
Gift(G) | 3 | $0 | 0.0% |
Insiders at Acurx Pharmaceuticals, Inc. are accumulating shares at an accelerated pace. With 3 insiders making 13 transactions totaling $374.6K in purchases versus $0 in sales, the net buying activity of $374.6K signals strong executive confidence. Carl Sailer (Executive) leads the buying activity with $245.0K in transactions across all time.